West Paces Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.1K Hold
155
– – ﹤0.01% 395
2026
Q2
$9.9K Buy
+155
New +$10.2K ﹤0.01% 388
2025
Q2
– Sell
-164
Closed -$13.2K – 343
2025
Q1
$13.2K Hold
164
– – ﹤0.01% 323
2024
Q4
$12.8K Hold
164
– – ﹤0.01% 330
2024
Q3
$15.4K Hold
164
– – ﹤0.01% 319
2024
Q2
$12.8K Sell
164
-2
-1% -$163 ﹤0.01% 327
2024
Q1
$15.1K Hold
166
– – ﹤0.01% 331
2023
Q4
$12.8K Buy
166
+2
+1% +$140 ﹤0.01% 341
2023
Q3
$11.2K Hold
164
– – ﹤0.01% 343
2023
Q2
$13.3K Sell
164
-145
-47% -$11.6K ﹤0.01% 345
2023
Q1
$25.3K Buy
+309
New +$22.1K 0.01% 284

Other funds holding GEHC

West Paces Advisors's GEHC Position: Q3 2026 in Review

West Paces Advisors held its GE HealthCare (GEHC) position steady in Q3 2026 at 155 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #395.

West Paces Advisors first reported a position in GEHC in Q1 2023 and has held it in 11 quarters since. The position peaked at $25.3K in Q1 2023. 609 funds tracked by Wall St. Rank hold GEHC as of Q3 2026.

  • West Paces Advisors held 155 shares of GE HealthCare worth $10.1K as of Q3 2026.
  • West Paces Advisors left its GE HealthCare share count unchanged in Q3 2026.
  • GE HealthCare made up ﹤0.01% of West Paces Advisors's portfolio in Q3 2026, its #395 holding.
  • West Paces Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 11 quarters since.
  • West Paces Advisors's GE HealthCare position peaked at $25.3K in Q1 2023.
  • 609 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2026.

Based on West Paces Advisors's 13F filing for Q3 2026, filed 13 Oct 2026.